Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep102 | Adrenal and Cardiovascular Endocrinology | ECE2022

Factors associated with metabolic syndrome in tunisian psychiatric patients

Missaoui Abdel Mouhaymen , Jdira Salem , Trimeche Oumeyma , Hsine Houda , Abbes Wafa , Khochtali Ines

Introduction: Metabolic Syndrome (MetS) is a bunch of metabolic disturbances related to insulin resistance and is considered a global public health problem. The screening and management of MetS is particularly challenging in psychiatric practice.Objectives: We aim to identify clinical and therapeutic factors associated with MetS in a Tunisian psychiatric population.Methods: We conducted a descriptive and analytical cross-sectional ...

ea0081ep440 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Metabolic syndrome in mediterranean patients with mental illness

Jdira Salem , Missaoui AbdelMouhaymen , Trimeche Oumeyma , Hsine Houda , Abbes Wafa , Khochtali Ines

Introduction: Metabolic Syndrome (MetS) represents a cluster of vascular risk factors related to insulin resistance such as abdominal obesity, hypertension, and glucose and lipid dysregulations. Multiple studies suggest an increasing metabolic risk in psychiatric patients. ObjectivesWe aim to assess epidemiological and clinical features of MetS in a Mediterranean psychiatric population. MethodsWe conducted a descriptive cross-sectional study involving 126 patients attending th...

ea0081ep504 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Metabolic burden in mediterranean patients with schizophrenia and psychotic disorders

Missaoui AbdelMouhaymen , Jdira Salem , Trimeche Oumeyma , Hsine Houda , Abbes Wafa , Khochtali Ines

Introduction: Mortality among patients with schizophrenia and psychotic disorders(SAPD) is two to threefold higher than in the general population and is widely attributed to cardiovascular and metabolic morbidity.Objectives: We aim to highlight the metabolic profile of Mediterranean patients diagnosed with SAPD.Methods: We conducted a descriptive and analytical cross-sectional study involving 55 patients who attended the psychiatry...

ea0090ep364 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Erectile dysfunction: An early warning sign of urinary disorders in men suffering from diabetes

Haj Kacem Akid Faten , Missaoui Abdel Mouhaymen , Soomauroo Siddiqa , Trimeche Oumeyma , Majdoub Nabila Rekik , Salah Dhoha Ben , Hedi Mohamed Abid

Objective: To determine the prevalence and analyze the predictive value of erectile dysfunction (ED) in the occurrence of fictional disorders (MD) in men with diabetes mellitus (DM).Patients and Methods: Cross-sectional study of 90 men presenting with DM. A comparative analysis was performed between two subgroups: G1 (n=75) with MD vs G2 (n=15) without MD.Results: G1 patients were older than G2 (59.7±10.3 vs 58...

ea0081ep1161 | Thyroid | ECE2022

Case report: Amiodarone-induced thyroid dysfunction

Akid Faten Haj Kacem , Trimeche Oumeyma , Missaoui AbdelMouhaymen , Salah Dhoha Ben , Fatma Mnif , Charfi Nadia , Mnif Mouna , Majdoub Nabila Rekik , Elleuch Mouna , Abid Mohamed

Amiodarone is considered by many the most potent antiarrhythmic drug. The other side of the coin is that it’s associated with many side effects including disturbances in the thyroid function, which can be seen in 14 to 18 % of the cases (1). This case is about a 56-year-old male patient with a history of mitral valve disease who was on Amiodarone for 3 years. His personal history was notable with Epilepsy of unknow etiology for which he was on sodium valproate. During fol...

ea0090p694 | Pituitary and Neuroendocrinology | ECE2023

Management challenges of gestational pituitary adenoma

Fatma Mnif , Trimeche Oumeyma , Mouhaymen Missaoui Abdel , Ben Salah Dhoha , Elleuch Mouna , Haj Kacem Akid Faten , Charfi Nadia , Mnif Mouna , Rekik Majdoub Nabila , Abid Mohamed

Pituitary apoplexy is a rare condition and gestational pituitary apoplexy (GPA) is even more exceptional. Clinical presentation of GPA is often non-specific overlapping with other conditions, making its diagnosis challenging. Additionally, therapeutic management is often limited since it depends on both the mother’s and the fetus’s prognosis. Herein we report of a woman who was diagnosed with GPA and we discuss the management of her case. A 34-year-old woman with no ...

ea0090p196 | Reproductive and Developmental Endocrinology | ECE2023

Metabolic syndrome in Turner syndrome

Haj Kacem Akid Faten , Trimeche Oumeyma , Mnif Mouna , Mouhaymen Missaoui Abdel , Ben Salah Dhoha , Elleuch Mouna , Fatma Mnif , Charfi Nadia , Rekik Majdoub Nabila , Abid Mohamed

Introduction: Turner syndrome (TS) is a feminine chromosomic disease, defined as the partial or total loss of the X chromosome. Classic phenotype includes growth and pubertal retardation as well as a characteristic dysmorphic syndrome. Other accompanying comorbidities are frequently associated with TS such as metabolic diseases: overweight, diabetes, hypertension (HTA) and dyslipidemia. Through this report we aim to determine the frequency of metabolic diseases associated with...

ea0090p445 | Reproductive and Developmental Endocrinology | ECE2023

Auto-immune diseases in Turner syndrome

Haj Kacem Akid Faten , Trimeche Oumeyma , Mnif Mouna , Khochtali Rihab , Ben Salah Dhoha , Elleuch Mouna , Fatma Mnif , Charfi Nadia , Rekik Majdoub Nabila , Abid Mohamed

Introduction: Turner syndrome (TS) is a genetic disease, attributable to the total or partial loss of an X chromosome. The classic phenotype encompasses short stature, hypergonadotropic hypogonadism and dysmorphic features. It’s also associated with other conditions such as autoimmune (AI) diseases. Aim: Herein we aim to determine the frequency of AI diseases in TS and to identify the genetic variants of TS mostly associated with this latter conditi...

ea0090p466 | Reproductive and Developmental Endocrinology | ECE2023

Hyperprolactinemia in Turner syndrome

Haj Kacem Akid Faten , Trimeche Oumeyma , Mnif Mouna , Hamdi Frikha , Ben Salah Dhoha , Elleuch Mouna , Fatma Mnif , Charfi Nadia , Rekik Majdoub Nabila , Abid Mohamed

Introduction: Hyperprolactinemia is a relatively frequent finding. A wide range of conditions can be responsible of this biochemical abnormality. Herein we report a rather rare etiology of hyperprolactinemia which is Turner syndrome (TS).Methods: Aiming to determine the frequency of hyperprolactinemia in patients with TS, we enrolled a retrospective descriptive study in the department of Endocrinology at the Hedi Chaker Hospital. We included patients who...

ea0090ep916 | Reproductive and Developmental Endocrinology | ECE2023

Coexistence of Turner syndrome and Rokitansky-Küster-Hauser

Haj Kacem Akid Faten , Trimeche Oumeyma , Mnif Mouna , Mouhaymen Missaoui Abdel , Ben Salah Dhoha , Elleuch Mouna , Fatma Mnif , Charfi Nadia , Rekik Majdoub Nabila , Abid Mohamed

Introduction: Turner syndrome (TS) is a genetic condition, that results from the complete or partial loss of the second X chromosome in phenotypic females. Typically, patients with TS have growth retardation, altered pubertal development and facial dysmorphism. It’s also associated with other comorbidities.Aim: Here we report a rather rare finding which is the association of TS and Rokitansky-Küster Hauser (RKH) and we discuss the possible ethi...